Furthermore, CD87/IL-12 CAR-T cells exhibited enhanced antitumor activity, inducing tumor regression more effectively than CD87 single-target CAR-T cells in both in vivo studies and three-dimensional co-culture models. The gene discussed is PLAUR; the disease is neoplasm.